Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study.
- Published in:
- Oncology, 2022, v. 100, n. 2, p. 124, doi. 10.1159/000519767
- By:
- Publication type:
- Article
Works by Upton, Alexander
Results: 2
1
2
Developing a Framework for the Health Technology Assessment of Histology-independent Precision Oncology Therapies.
- Published in:
- Applied Health Economics & Health Policy, 2021, v. 19, n. 5, p. 625, doi. 10.1007/s40258-021-00654-4
- By:
- Publication type:
- Article